Syncona investee Freeline narrows quarterly loss as costs fall
Healthcare company investor Syncona Ltd on Wednesday noted that its portfolio company Freeline Therapeutics PLC trimmed its loss for the first quarter of 2022.
Freeline's...
Wed, 11/05/2022 - 09:30